- $11.70bn
- $11.40bn
- $5.99bn
- 63
- 74
- 79
- 83
Annual cashflow statement for Globe Life, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 745 | 740 | 971 | 1,071 | — |
| Amortisation | |||||
| Non-Cash Items | 0 | — | — | — | — |
| Discontinued Operations | |||||
| Changes in Working Capital | 88.9 | 58.1 | 132 | -78.3 | — |
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Gains / Losses on Investment Securities | |||||
| Change in Deferred Policy Acquisition Costs | |||||
| Cash from Operating Activities | 1,438 | 1,422 | 1,482 | 1,402 | — |
| Capital Expenditures | -38.2 | -27.9 | -49.6 | -71 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -875 | -915 | -877 | -570 | — |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Policy Loans | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -913 | -943 | -926 | -642 | — |
| Financing Cash Flow Items | -71.9 | -118 | -97.7 | -309 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -524 | -492 | -541 | -716 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.68 | 0.396 | 10.6 | 62.2 | — |